| Name | Title | Contact Details |
|---|
Woodcock Washburn is a Philadelphia, PA-based company in the Healthcare, Pharmaceuticals, & Biotech sector.
We founded Cedilla at a time of fundamental and rapidly growing insight into the mechanisms underlying protein stability. Small molecules that degrade or stablize target proteins are precedented, but have been discovered serendipitously. Cedilla is taking an integrated approach to discover new drugs with this mode of action. Our present focus is to develop novel medicines in oncology, but this approach will also be applicable to other fields, including central nervous system disorders and genetic diseases. Cedilla launched with $56.2 million in Series A funding from Third Rock Ventures.
University Technologies International is a Calgary, AB-based company in the Healthcare, Pharmaceuticals, & Biotech sector.
Sigtem Technology Inc is a Harleysville, PA-based company in the Healthcare, Pharmaceuticals, & Biotech sector.
Gennao Bio is a privately held genetic medicines company developing first-in-class targeted nucleic acid therapeutics utilizing a proprietary gene monoclonal antibody (GMAB) platform technology.